StockNews.com Initiates Coverage on Milestone Scientific (NYSE:MLSS)

Research analysts at StockNews.com began coverage on shares of Milestone Scientific (NYSE:MLSS) in a note issued to investors on Monday. The firm set a “hold” rating on the stock.

Separately, Benchmark assumed coverage on shares of Milestone Scientific in a research report on Thursday, October 10th. They issued a “speculative buy” rating and a $1.25 price target on the stock.

Milestone Scientific Price Performance

NYSE MLSS opened at $0.62 on Monday. The business’s fifty day moving average is $0.84 and its 200-day moving average is $0.84. The stock has a market capitalization of $48.30 million, a price-to-earnings ratio of -8.86 and a beta of 1.08. Milestone Scientific has a one year low of $0.52 and a one year high of $1.10.

Insider Buying and Selling at Milestone Scientific

In other news, Director Leonard Osser sold 107,984 shares of the company’s stock in a transaction dated Tuesday, October 22nd. The stock was sold at an average price of $0.93, for a total value of $100,425.12. Following the completion of the transaction, the director now directly owns 4,606,882 shares in the company, valued at approximately $4,284,400.26. This represents a 2.29 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders sold a total of 109,193 shares of company stock worth $101,634 over the last three months. 24.75% of the stock is owned by insiders.

Hedge Funds Weigh In On Milestone Scientific

A hedge fund recently raised its stake in Milestone Scientific stock. Geode Capital Management LLC increased its stake in shares of Milestone Scientific Inc. (NYSE:MLSS) by 6.4% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 527,005 shares of the company’s stock after acquiring an additional 31,572 shares during the quarter. Geode Capital Management LLC owned approximately 0.68% of Milestone Scientific worth $480,000 as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors and hedge funds own 5.79% of the company’s stock.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.